{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/pasireotide.json","peptide":{"slug":"pasireotide","name":"Pasireotide","url":"https://peptidescanner.com/peptides/pasireotide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":63,"entries":[{"objectId":"story:clinicaltrials-gov-nct00171730-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00171730","domain":"Clinical trials","dateInSource":"2021-09-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00171730-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00171730-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct00171730-pasireotide-v1","contentSha256":"8fc94c57bb95149f94983fa51272e0b90897103e237a65277801ee2d1103837a"},{"objectId":"story:clinicaltrials-gov-nct00171951-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00171951","domain":"Clinical trials","dateInSource":"2021-06-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00171951-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00171951-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct00171951-pasireotide-v1","contentSha256":"44744f90b183b39a9f7080811e95fa4047ebb4ed796edcb28e0f677c81e2d56f"},{"objectId":"story:clinicaltrials-gov-nct00434148-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00434148","domain":"Clinical trials","dateInSource":"2016-03-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00434148-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00434148-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct00434148-pasireotide-v1","contentSha256":"5043a4a81cb942cd8b0fb692a61c0a135c228a0881ad4022b609c47da3f311ba"},{"objectId":"story:clinicaltrials-gov-nct00446082-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00446082","domain":"Clinical trials","dateInSource":"2020-12-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00446082-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00446082-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct00446082-pasireotide-v1","contentSha256":"ef619114deafe85c5f54490a0bba4250b4720307587f4ea4bfce143e1b5e0813"},{"objectId":"story:clinicaltrials-gov-nct00698464-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00698464","domain":"Clinical trials","dateInSource":"2020-12-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00698464-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00698464-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct00698464-pasireotide-v1","contentSha256":"5ce90f707ef0aae29ebca9ff704b0a13e1c9135f3267766632f6505367de2a4f"},{"objectId":"story:clinicaltrials-gov-nct00804336-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT00804336","domain":"Clinical trials","dateInSource":"2016-10-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00804336-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00804336-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct00804336-pasireotide-v1","contentSha256":"b69d0c11986870b859ed8528be12a57f24108efcbd580a4587ae6e008b4c0ffe"},{"objectId":"story:clinicaltrials-gov-nct01128192-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01128192","domain":"Clinical trials","dateInSource":"2014-12-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01128192-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01128192-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01128192-pasireotide-v1","contentSha256":"7d141f2b595e31a363531cfc1e52976136d9450348c306eb36aefc120e5d60ca"},{"objectId":"story:clinicaltrials-gov-nct01137682-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01137682","domain":"Clinical trials","dateInSource":"2018-04-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01137682-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01137682-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01137682-pasireotide-v1","contentSha256":"56cfe90889206662650c30fbcf7b310266972865f484f6adbcb9d6483a1a02cd"},{"objectId":"story:clinicaltrials-gov-nct01270321-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01270321","domain":"Clinical trials","dateInSource":"2021-02-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01270321-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01270321-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01270321-pasireotide-v1","contentSha256":"daaed4e20826c2f4e2f71c9e655ac0fcfdfc6ef42ce84688794342ced4d7b517"},{"objectId":"story:clinicaltrials-gov-nct01356862-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01356862","domain":"Clinical trials","dateInSource":"2017-01-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01356862-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01356862-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01356862-pasireotide-v1","contentSha256":"9a2c20b5625c027d95ac6c5cb12c8ecea9b4e973ddfd5b961e0a1e640538a6ee"},{"objectId":"story:clinicaltrials-gov-nct01385956-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01385956","domain":"Clinical trials","dateInSource":"2020-09-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01385956-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01385956-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01385956-pasireotide-v1","contentSha256":"b8df8fff2f08d4ffbd4c99aca546ca7ecd80c335fce54bdfc3f5760e797decbd"},{"objectId":"story:clinicaltrials-gov-nct01468532-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01468532","domain":"Clinical trials","dateInSource":"2021-03-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01468532-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01468532-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01468532-pasireotide-v1","contentSha256":"ffda1b790794637603f8d166e0d3a3d9fc11e30aebd44101ab84c1e7618f23ee"},{"objectId":"story:clinicaltrials-gov-nct01469572-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01469572","domain":"Clinical trials","dateInSource":"2018-10-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01469572-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01469572-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01469572-pasireotide-v1","contentSha256":"8dedfab2e50539da082454bc09dfe0e0f80480cf6633ec992e641076acfae0a6"},{"objectId":"story:clinicaltrials-gov-nct01488487-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01488487","domain":"Clinical trials","dateInSource":"2016-04-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01488487-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01488487-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01488487-pasireotide-v1","contentSha256":"01d174c46d7e3f8eba04c4d786c3cb25602d74f27a2a90f02c3cde7e11f0706d"},{"objectId":"story:clinicaltrials-gov-nct01620138-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01620138","domain":"Clinical trials","dateInSource":"2016-08-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01620138-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01620138-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01620138-pasireotide-v1","contentSha256":"465a86c65a597dcfe6acc8508ab696fa49bebf8472ac2ccd2fe98efae698ab59"},{"objectId":"story:clinicaltrials-gov-nct01637272-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01637272","domain":"Clinical trials","dateInSource":"2017-05-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01637272-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01637272-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01637272-pasireotide-v1","contentSha256":"d0d788aa8dbcddd72b5e795d8545d8691c95eedc6d4bc262ffdd0dd7d1af3688"},{"objectId":"story:clinicaltrials-gov-nct01794793-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01794793","domain":"Clinical trials","dateInSource":"2024-10-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01794793-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01794793-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01794793-pasireotide-v1","contentSha256":"8b73c13dfb3203cb8c1b96d8ad4481b7c3776fb2318d5945d18f5d95e61bbfec"},{"objectId":"story:clinicaltrials-gov-nct01895296-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01895296","domain":"Clinical trials","dateInSource":"2013-07-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01895296-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01895296-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct01895296-pasireotide-v1","contentSha256":"bf9d00eeac1286e6c90e98d02767e7135bdc82c9b2c833659f4e8d9fcac57ebd"},{"objectId":"story:clinicaltrials-gov-nct02021942-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02021942","domain":"Clinical trials","dateInSource":"2018-02-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02021942-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02021942-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02021942-pasireotide-v1","contentSha256":"6fd6bf5b5af13fb50372a6441f02bf84f20d9facb358d9f756fbac01e3c83172"},{"objectId":"story:clinicaltrials-gov-nct02215070-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02215070","domain":"Clinical trials","dateInSource":"2021-11-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02215070-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02215070-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02215070-pasireotide-v1","contentSha256":"3ebe4302b37471b8bf93ab04c90f8e93c766d11b8d591e2a1456b2eed1ef2f96"},{"objectId":"story:clinicaltrials-gov-nct02310269-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02310269","domain":"Clinical trials","dateInSource":"2024-10-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02310269-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02310269-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02310269-pasireotide-v1","contentSha256":"abb6224029c35f01ba896ebe31a5efff582be1da42ffeac146d3a07539fab62d"},{"objectId":"story:clinicaltrials-gov-nct02527993-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02527993","domain":"Clinical trials","dateInSource":"2018-03-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02527993-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02527993-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02527993-pasireotide-v1","contentSha256":"12e0764bd88db5969c36022cea02488800395f649f3eeaf41f8f39a41e404dc3"},{"objectId":"story:clinicaltrials-gov-nct02622906-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02622906","domain":"Clinical trials","dateInSource":"2015-12-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02622906-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02622906-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02622906-pasireotide-v1","contentSha256":"0298c934a66d55c210fb0120447b64478d21c93b01313213642fd631727ea603"},{"objectId":"story:clinicaltrials-gov-nct02713776-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02713776","domain":"Clinical trials","dateInSource":"2025-12-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02713776-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02713776-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02713776-pasireotide-v1","contentSha256":"323e0025085022fac890db0e277460c3ef681b9da529e12783fc313b6e91c62a"},{"objectId":"story:clinicaltrials-gov-nct02775227-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02775227","domain":"Clinical trials","dateInSource":"2020-08-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02775227-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02775227-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct02775227-pasireotide-v1","contentSha256":"6c1d9deecffe4d89c88202db1fb9aec4e7809993e6a97868c50f4bee754741b3"},{"objectId":"story:clinicaltrials-gov-nct03103009-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03103009","domain":"Clinical trials","dateInSource":"2021-09-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03103009-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct03103009-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct03103009-pasireotide-v1","contentSha256":"c8220730ffeacc6f6fdaac76a1358f7114e5280806826d1604a1b57d64e7b5c5"},{"objectId":"story:clinicaltrials-gov-nct03847207-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03847207","domain":"Clinical trials","dateInSource":"2025-02-19","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03847207-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct03847207-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct03847207-pasireotide-v1","contentSha256":"95f9aafdd02042d57fee51b59532e8f328885e43ae413e8f30a328c3628b7b4b"},{"objectId":"story:clinicaltrials-gov-nct05928390-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT05928390","domain":"Clinical trials","dateInSource":"2026-09-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05928390-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct05928390-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct05928390-pasireotide-v1","contentSha256":"5fc643c6e936f6043efa28195c4ebb88e2739e071a1dbaa5d462b087e3f87f3d"},{"objectId":"story:clinicaltrials-gov-nct06295952-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT06295952","domain":"Clinical trials","dateInSource":"2026-03-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06295952-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct06295952-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct06295952-pasireotide-v1","contentSha256":"b91d0b5eb5f0c5064365b508a24c3a66396c911fabb17cb5f62c1dd22d343f01"},{"objectId":"story:clinicaltrials-gov-nct06456359-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT06456359","domain":"Clinical trials","dateInSource":"2025-01-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06456359-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct06456359-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#clinicaltrials-gov-nct06456359-pasireotide-v1","contentSha256":"b58c3ccab7178be900b0529593b622aa5cc4ba8e9c6a4a29140ef161bdc3898f"},{"objectId":"story:fda-drugs-nda200677:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA200677","domain":"Regulatory","dateInSource":"2012-12-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda200677/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#fda-drugs-nda200677-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#fda-drugs-nda200677-v1","contentSha256":"6947713b4f70cf263ee5799e1ff96b1e674bf640b397fbdd44cc0e298290bc98"},{"objectId":"story:federal-register-2012-25483:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2012-25483","domain":"Regulatory","dateInSource":"2012-10-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2012-25483/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#federal-register-2012-25483-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#federal-register-2012-25483-v1","contentSha256":"04766fc80a5dcf4ec0766ab2e89c826e93cd67310ca3c615373f4be84d76d223"},{"objectId":"story:federal-register-2015-10994:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2015-10994","domain":"Regulatory","dateInSource":"2015-05-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2015-10994/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#federal-register-2015-10994-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#federal-register-2015-10994-v1","contentSha256":"be5f0061b0755102902653ca4355224f54ea876fe7e86757f3e141df387a985e"},{"objectId":"story:pubmed-pmid-18957506-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.","domain":"Literature metadata","dateInSource":"2022-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-18957506-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-18957506-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-18957506-pasireotide-v1","contentSha256":"be9ac9789c5aa7364ca9c98e6ad0cf8786b0284b14044f1559884a08671f16e7"},{"objectId":"story:pubmed-pmid-20463350-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.","domain":"Literature metadata","dateInSource":"2022-03-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20463350-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-20463350-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-20463350-pasireotide-v1","contentSha256":"24cfe5fd4802d9b9c8a095b07d86676b052ecee0beda862b8442957699cb3df9"},{"objectId":"story:pubmed-pmid-20533892-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide for the treatment of Cushing's disease.","domain":"Literature metadata","dateInSource":"2014-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20533892-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-20533892-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-20533892-pasireotide-v1","contentSha256":"b299616e535ed98e5fdc8e77c0e2ff075670a08b92e8e310178c96a212ab649f"},{"objectId":"story:pubmed-pmid-23228667-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide.","domain":"Literature metadata","dateInSource":"2026-01-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23228667-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23228667-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-23228667-pasireotide-v1","contentSha256":"38aa1444d15f42ae5748a2ebfabb9be4b4a41a0d982ed1e97ae8503983003f48"},{"objectId":"story:pubmed-pmid-23605695-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide: a review of its use in Cushing's disease.","domain":"Literature metadata","dateInSource":"2026-10-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23605695-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23605695-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-23605695-pasireotide-v1","contentSha256":"1d6ef0c4da712707f37008421d39179ca4d77d7e00cf577dfad5b79c2cefbc2b"},{"objectId":"story:pubmed-pmid-23669783-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireoride (Signifor) for Cushing's disease.","domain":"Literature metadata","dateInSource":"2014-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23669783-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23669783-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-23669783-pasireotide-v1","contentSha256":"de4f27f757d61b1c93050c9619ec0847f9221c6c81df51158201cfeef4417db1"},{"objectId":"story:pubmed-pmid-23680921-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Assessment of the absorption, metabolism and excretion of [¹⁴C]pasireotide in healthy volunteers using accelerator mass spectrometry.","domain":"Literature metadata","dateInSource":"2014-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-23680921-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23680921-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-23680921-pasireotide-v1","contentSha256":"281c734aeeec72e1a7131b7fc9766039aebff07e9dffa695d22179bf00583c83"},{"objectId":"story:pubmed-pmid-24126229-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide and mifepristone: new options in the medical management of Cushing's disease.","domain":"Literature metadata","dateInSource":"2021-02-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24126229-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-24126229-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-24126229-pasireotide-v1","contentSha256":"9fa168647b53528a2122ae10d63731e4dec1099c75c1da01c12e550e2efac6ef"},{"objectId":"story:pubmed-pmid-24287689-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial.","domain":"Literature metadata","dateInSource":"2022-03-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24287689-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-24287689-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-24287689-pasireotide-v1","contentSha256":"c70156c7ea80ace3bdcf6d54f8090605fd35bda3df95d23dc61ee1fd1c690f29"},{"objectId":"story:pubmed-pmid-25003365-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Long-term medical treatment of cushing's disease with pasireotide: a review of current evidence and clinical experience.","domain":"Literature metadata","dateInSource":"2014-09-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25003365-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-25003365-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-25003365-pasireotide-v1","contentSha256":"164373ed229467ef4e545a44dfdfb7eab623467f88309203b1dae4c38450e719"},{"objectId":"story:pubmed-pmid-25613083-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.","domain":"Literature metadata","dateInSource":"2022-03-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-25613083-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-25613083-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-25613083-pasireotide-v1","contentSha256":"46dbb231965081f569919c1f5cc9f475c42f4d6f13c406053ed41cb130f6d8ef"},{"objectId":"story:pubmed-pmid-26275531-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.","domain":"Literature metadata","dateInSource":"2021-02-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26275531-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-26275531-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-26275531-pasireotide-v1","contentSha256":"a901731f13ad9a37c967d3b27278e92f68258ef60ad94ef585912bf1f01e6094"},{"objectId":"story:pubmed-pmid-26808354-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide for the treatment of acromegaly.","domain":"Literature metadata","dateInSource":"2022-03-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26808354-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-26808354-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-26808354-pasireotide-v1","contentSha256":"1ce8509e9f15692a89836d0802d3f1c3b4c553625e9538ebec55c177857696dc"},{"objectId":"story:pubmed-pmid-27473537-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.","domain":"Literature metadata","dateInSource":"2026-01-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27473537-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-27473537-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-27473537-pasireotide-v1","contentSha256":"38ecbabe5886235f8cac1f74ba6614f5fc5e630656b7537f22fb863c1cd1b87d"},{"objectId":"story:pubmed-pmid-29396758-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Insulin sensitivity and secretion and adipokine profile in patients with Cushing's disease treated with pasireotide.","domain":"Literature metadata","dateInSource":"2019-01-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29396758-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-29396758-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-29396758-pasireotide-v1","contentSha256":"df19acbbddd7df9346f3cbb324ca2f16bfedd788d0b7224d85f6f210c8aa96a8"},{"objectId":"story:pubmed-pmid-29534939-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer.","domain":"Literature metadata","dateInSource":"2019-02-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29534939-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-29534939-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-29534939-pasireotide-v1","contentSha256":"3eddfea3892c39d398c5ae40691c025f5be1f5f9e6288236dc85f608c9d6ae9a"},{"objectId":"story:pubmed-pmid-30608534-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"How to Position Pasireotide LAR Treatment in Acromegaly.","domain":"Literature metadata","dateInSource":"2020-05-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30608534-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-30608534-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-30608534-pasireotide-v1","contentSha256":"9ada0fd632983e65e6c79a47de47184e660417bb3ab4bbbd7d7c0915ff2e75ab"},{"objectId":"story:pubmed-pmid-32843370-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial.","domain":"Literature metadata","dateInSource":"2024-08-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32843370-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-32843370-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-32843370-pasireotide-v1","contentSha256":"c769c897c4ed4ef5cb14726837ce35efe45a463f7e16dfdf400f5e04ac839d78"},{"objectId":"story:pubmed-pmid-35518928-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.","domain":"Literature metadata","dateInSource":"2023-11-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35518928-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-35518928-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-35518928-pasireotide-v1","contentSha256":"2cd5f05495eb7cfc3f6915376a896b61d30345c4d128d3f10f103759152d1a40"},{"objectId":"story:pubmed-pmid-35670988-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pituitary acting drugs: cabergoline and pasireotide.","domain":"Literature metadata","dateInSource":"2026-10-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35670988-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-35670988-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-35670988-pasireotide-v1","contentSha256":"eb7e0ae7222b330b1b97103f55182aff1303cde61340a59c1ce86a00203e0a13"},{"objectId":"story:pubmed-pmid-35931640-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Second line treatment of acromegaly: Pasireotide or Pegvisomant?","domain":"Literature metadata","dateInSource":"2022-12-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35931640-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-35931640-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-35931640-pasireotide-v1","contentSha256":"6893ecc5577b3c470353a2cb389f1f5011714d72966825f5909517bfbe3b1821"},{"objectId":"story:pubmed-pmid-38577574-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study.","domain":"Literature metadata","dateInSource":"2026-06-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38577574-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38577574-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-38577574-pasireotide-v1","contentSha256":"ea676f129326c38ba95400af3e9db8916db04d3c4287dfbd0e64fd6a016a1624"},{"objectId":"story:pubmed-pmid-38713182-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.","domain":"Literature metadata","dateInSource":"2026-09-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38713182-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38713182-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-38713182-pasireotide-v1","contentSha256":"052f0c9593ca6c6dc78770b9e387b2230feab59649b6da5ec41f0dd0847eeacc"},{"objectId":"story:pubmed-pmid-38817802-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences.","domain":"Literature metadata","dateInSource":"2024-06-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38817802-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38817802-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-38817802-pasireotide-v1","contentSha256":"e1f2109c7cf09333e13604b648aeea20101bf3c653ea1073b3af383599a82a20"},{"objectId":"story:pubmed-pmid-38982703-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR.","domain":"Literature metadata","dateInSource":"2024-07-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38982703-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38982703-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-38982703-pasireotide-v1","contentSha256":"10b166aee658551be79f13b33dace9f269ea7a02861a818f10730ca4504a22b1"},{"objectId":"story:pubmed-pmid-39072348-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Management of Diabetes Mellitus in Acromegaly and Cushing's Disease with Focus on Pasireotide Therapy: A Narrative Review.","domain":"Literature metadata","dateInSource":"2024-07-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39072348-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-39072348-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-39072348-pasireotide-v1","contentSha256":"f13c35823cc404a1bf9ad5586bcff517bd06e74d87b9057dc4bf4a8830d1fac3"},{"objectId":"story:pubmed-pmid-39129819-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly.","domain":"Literature metadata","dateInSource":"2024-08-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39129819-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-39129819-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-39129819-pasireotide-v1","contentSha256":"1f94967001a336a54717a158355abedecfe94210c18cb6ce033c08096aac9b23"},{"objectId":"story:pubmed-pmid-40283624-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.","domain":"Literature metadata","dateInSource":"2025-04-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-40283624-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-40283624-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-40283624-pasireotide-v1","contentSha256":"9595d730561c96b06eda66f9b73bdaff765cd3219b34074a3281a8fd15cca27b"},{"objectId":"story:pubmed-pmid-41323967-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real-life data on pasireotide in monotherapy or combined in active Cushing's disease.","domain":"Literature metadata","dateInSource":"2025-12-03","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41323967-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-41323967-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-41323967-pasireotide-v1","contentSha256":"63e12253f53080efe1d4b6318dc1ebffeed257bdb786d0f95490fcaf21f8affc"},{"objectId":"story:pubmed-pmid-42778805-pasireotide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas.","domain":"Literature metadata","dateInSource":"2026-10-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42778805-pasireotide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-42778805-pasireotide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/pasireotide.md#pubmed-pmid-42778805-pasireotide-v1","contentSha256":"1dbe12581f156e6c11d16ff2b4aca6520fd27a8dcff467b34549626df259196f"}]}
